ASSURE Wearable ECG vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Kestra Medical Technologies
VS
by Volta Medical

AI Verdict

Tool A focuses on continuous, remote heart rate monitoring and data collection for at-risk cardiac patients, emphasizing diagnostics and long-term trends. In contrast, Tool B is an AI-powered software providing real-time assistance to electrophysiologists during cardiac ablation procedures for identifying abnormal electrograms. While both utilize AI in cardiology, they address different stages of patient care: remote monitoring versus intra-procedural guidance.

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you require continuous, long-term heart rate monitoring and comprehensive data collection for at-risk cardiac patients outside of a clinical setting. This tool is ideal for remote patient management, providing clinicians with physiologic trend data and alert-based notifications to proactively manage patient care.

View ASSURE Wearable ECG →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and need real-time, AI-powered assistance. This software is specifically designed to integrate with existing EP lab systems to identify abnormal electrograms and guide catheter placement during the procedure, aiming to improve procedural outcomes.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ASSURE Wearable ECG VX1+
Deployment The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool A emphasizes an 'intuitive' and 'mobile' experience for patients with its comfortable 'SensorFit Garment' and a 'cloud-based remote patient data platform' for clinicians. This suggests a broader ease of use across different user types and contexts. While Tool B offers a 'simple user interface with color coding' for specialists, Tool A's focus on patient comfort and a comprehensive platform for review gives it an edge in overall usability.

Clinical Value

VX1+

Tool B provides real-time, AI-driven insights directly assisting electrophysiologists during complex cardiac ablation procedures to identify abnormal electrograms. This direct, immediate decision support during an invasive intervention offers a critical impact on procedural success. Tool A provides valuable continuous monitoring and early detection, but Tool B's role in guiding a high-stakes procedure gives it a higher immediate clinical impact.

Pricing & Value

Tie

Both Tool A and Tool B explicitly state that their pricing information is not publicly available and requires direct contact for details. Without any transparent pricing, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition. Therefore, neither tool can be declared a winner in this dimension.

Enterprise Readiness

ASSURE Wearable ECG

Tool A explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, alongside FDA clearance and a cloud-based deployment model. These explicit compliance claims are crucial for enterprise adoption and data security. While Tool B also has FDA clearance and integrates with existing hospital systems, its BAA and HIPAA compliance are not explicitly stated in the provided facts, giving Tool A a slight advantage in documented readiness.

Innovation

VX1+

Tool B demonstrates significant innovation by applying AI in real-time to provide critical decision support during complex, invasive cardiac ablation procedures, directly guiding electrophysiologists. This real-time AI assistance in a surgical setting represents a cutting-edge application of AI in healthcare. Tool A's innovation focuses on enhancing continuous wearable monitoring through advanced sensor design and artifact reduction, which is valuable but less directly impactful on real-time procedural decision-making.

Support & Docs

Tie

The structured facts provided for both Tool A and Tool B do not contain any information regarding the availability, quality, or extent of their support services or documentation. Without any data to compare, it is impossible to distinguish between the two tools on this dimension. Therefore, this dimension results in a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ASSURE Wearable ECG VX1+
Name ASSURE Wearable ECG VX1+
Company Kestra Medical Technologies Volta Medical
Description A non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Surgical AI
Key Features Wearable ECG device for continuous heart rate monitoring, SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors, ASSURE Detection Algorithm with Quad Channel Processingu2122, Adaptive Patient Intelligenceu2122 for filtering motion artifacts, Automatic episode storage, Alert-based notifications, Physiologic trend data, Kestra CareStation remote patient data platform for clinician review Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart, Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures, AI-driven insights to assist electrophysiologists during ablation procedures, Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system), Non-sterile reusable medical device, Simple user interface with color coding for electrogram dispersion (blue, orange, red), Booster mode for increased sensitivity during AT or slow AF, Provides cycle length estimation from electrograms

Videos

Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ASSURE Wearable ECG is a non-therapeutic device designed for continuous heart rate monitoring and data collection for at-risk cardiac patients, providing physiologic trend data and alert-based notifications. In contrast, VX1+ is AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
The ASSURE Wearable ECG system includes a wearable device, a mobile application, and a cloud-based remote patient data platform (Kestra CareStation) for clinician review. VX1+ is a software application that integrates with existing EP recording and 3D mapping systems, such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, or Abbott EnSite X 3D mapping system.
The ASSURE Wearable ECG collects continuous heart rate data using embedded ECG sensors and applies algorithms like Adaptive Patient Intelligence to filter motion artifacts. VX1+ analyzes electrograms to identify spatio-temporal dispersed electrograms (DEs) and provides cycle length estimation during AF and AT procedures.
No, the ASSURE Wearable ECG is designed for continuous monitoring of at-risk cardiac patients, typically in an ambulatory or remote setting. VX1+ is specifically used by electrophysiologists to assist during cardiac ablation procedures in an electrophysiology lab setting.
The ASSURE Wearable ECG utilizes a SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors, along with an ASSURE Detection Algorithm featuring Quad Channel Processing and Adaptive Patient Intelligence for artifact filtering. VX1+ employs AI-powered software to provide real-time manual or automatic annotation of 3D anatomical and electrical maps, identifying dispersed electrograms with features like a Booster mode for increased sensitivity.
Both the ASSURE Wearable ECG and VX1+ have FDA clearance. The ASSURE Wearable ECG is explicitly stated to be HIPAA compliant and has a Business Associate Agreement (BAA), while for VX1+, HIPAA compliance and BAA are noted as expected for a medical device handling patient data in the U.S.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.